Nuclear receptor subfamily 1 group I member 3 — Drug Target

All drugs that target Nuclear receptor subfamily 1 group I member 3 — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

phenytoin · Antiemetic

Marketed (2)

• Dilantin · Pfizer · phenytoin · Neuroscience
  Phenytoin exerts its therapeutic effect by voltage-dependent blockade of membrane sodium channels.
• Antivert · Citron Pharma Llc · Antiemetic · Other

Phase 2 pipeline (1)

• TIRACIZINE · Other